European Archives - Page 974 of 1138 - European Medical Journal

Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation

Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorders. Allogeneic stem cell transplantation (alloSCT) is the therapeutic approach…

Palliative Radiotherapy and Hormonal Deprivation for Prostate Cancer Induced Urinary Obstruction at a Sub-Saharan Tertiary Hospital

The occurrence of bladder outlet obstruction (BOO) in men with prostate cancer is common. Although relieving the obstruction may not change prognosis, it…

Liver Fibrosis Limited by Insulin-Like Growth Factor-I

FIBROSIS of the liver has been found to be limited by insulin-like growth factor-I (IGF-I), typically induced by growth hormones, according to a study by…

EMJ

Energy Drinks Associated with Hepatitis

ENERGY DRINKS have been associated with liver damage in a new case report authored by Dr Jennifer Harb, Department of Dermatology, University of…

EMJ

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

This symposium took place on 29th September 2016 as a part of the European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria…

EAACI Sheds Light on Recent Developments in Severe Asthma

United Kingdom, November 17, 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) hosts today in Manchester the 3rd International…

Introducing EMJ Dermatology 4.1

United Kingdom, November 15, 2016: Hello and welcome to this year’s EMJ Dermatology eJournal, updating the field with cutting-edge developments within…

EMJ

Epstein-Barr Virus: Cholestasis, Hepatitis, Or Both?

Epstein-Barr Virus (EBV), or more commonly known as the ‘kissing disease’ is seemingly unavoidable within the adolescent and teenage community.

Useful Photoprotection in Dermatological Practice

The main objectives of this symposium were to explore the effect of light on individuals with hyperpigmentation disorders and acne, present the latest…

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…